MedPath

Clinical Value of the MRI Combined With SCC-Ag for the Diagnosis of HSIL (CIN 2/3)

Completed
Conditions
Magnetic Resonance Imaging Examination
Interventions
Diagnostic Test: MRI,SCC-Ag
Registration Number
NCT05487209
Lead Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Brief Summary

The study aimed to identify the clinical value of Magnetic Resonance Imaging examination (MRI)combined with serum squamous cells carcinoma antigen (SCC-Ag) in women with high-grade squamous intraepithelial lesion (cervical intraepithelial neoplasia grades 2-3 (CIN 2-3)).

Detailed Description

186 female patients with the HSIL(CIN2-3) were included in this study and followed up from the time of admission. All patients underwent colposcopy examination, MRI, SCC-Ag, loop electrosurgical excision procedure (LEEP), extrafascial hysterectomy, or radical hysterectomy. Pathological findings of the patient's tissues were used as the final diagnostic criteria. On the one hand, we compared the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of MRI+SCC-Ag, LEEP of the menopausal group, and non-menopausal group. On the other hand, evaluating the accuracy of MRI combined with SCC-Ag examination in diagnosing HSIL(CIN2-3) by receiver-operating characteristic curve (ROC).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
186
Inclusion Criteria
  • No previous history of cervical lesions
  • TCT and HPV test results suspected cervical lesions
  • Further colposcopy showed HSIL or CIN 2-3
  • All selected patients underwent MRI, serological tests for SCC-Ag levels, LEEP, or radical hysterectomy
Exclusion Criteria
  • Patients with receiving cold knife conization
  • Patients with skin squamous cell carcinoma or previous history of cancer
  • Pregnant women
  • Patients with serious heart, liver, kidney, blood system and autoimmune diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
non-menopausal groupMRI,SCC-Ag-
postmenopausal groupMRI,SCC-Ag-
Primary Outcome Measures
NameTimeMethod
the number of cases whose combined diagnosis of MRI and SCC Ag for the non-menopausal group.20 days

In non-menopausal women, the number of cases whose combined diagnosis of MRI and SCC Ag consistent with the final pathological results

The number of cases whose combined diagnosis of MRI and SCC Ag In postmenopausal women20 days

In postmenopausal women, the number of cases whose combined diagnosis of MRI and SCC Ag consistent with the final pathological results

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The 2nd Affiliated Hospital and Yuying Children's Hospital of WMU

🇨🇳

Wenzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath